Literature DB >> 11750191

Efficient diagnostic test sequence: applications of the probability-modifying plot.

J L Severens1, G Sonke, R J Laheij, A L Verbeek, P F De Vries Robbé.   

Abstract

Excessive diagnostic testing rarely leads to complete certainty of the disease status of a patient. Because of constraints of health care budgets, physicians should be aware of the diminishing marginal gain of each subsequent test in a testing strategy related to costs. We developed the probability-modifying plot to determine economically efficient sequence of testing without losing clinical effectiveness. Two applications of the model are presented: diagnosis of Helicobacter pylori and diagnosis of benign prostatic hyperplasia. The probability-modifying plots are drawn to visualize and calculate the economic efficiency of all possible test sequences, meaning that although the different test sequences are equally accurate, some have even lower costs than others.

Entities:  

Mesh:

Year:  2001        PMID: 11750191     DOI: 10.1016/s0895-4356(01)00391-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Trends in ultrasound examination in family practice.

Authors:  Ali F Alamri; Israr Khan; Mirza I A Baig; Rahila Iftikhar
Journal:  J Family Community Med       Date:  2014-05

2.  Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.

Authors:  S R Clark; B T Baune; K O Schubert; S Lavoie; S Smesny; S M Rice; M R Schäfer; F Benninger; M Feucht; C M Klier; P D McGorry; G P Amminger
Journal:  Transl Psychiatry       Date:  2016-09-20       Impact factor: 6.222

Review 3.  Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments.

Authors:  Bethany Shinkins; Yaling Yang; Lucy Abel; Thomas R Fanshawe
Journal:  BMC Med Res Methodol       Date:  2017-04-14       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.